Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Select your origin of interest
Study found significant differences in transcript and protein expression, electrophysiological properties and proliferative capacity of NG2 (show Vcan Proteins) glia in the mouse forebrain, suggesting the co-existence of several subpopulations of NG2 (show Vcan Proteins) glia.
chondroitin sulfate proteoglycan 4 (CSPG4) is a potential mesenchymal progenitor cells marker.
Results suggest that NG2 (show Vcan Proteins) may counteract neurological deficits and adverse glial responses in traumatic brain injury
NG2 (show Vcan Proteins) protein is not required for glutamatergic neuron-NG2 (show Vcan Proteins) cell synaptic signaling
This study demonstrated that NG2 (show Vcan Proteins) is an important factor in OPC-dependent regeneration of white matter following spinal cord demyelination.
NF-kappaB (show NFKB1 Proteins) in NG2 (show Vcan Proteins)(+) cells promotes myoblast migration to the tips of myofibers through cell-cell contact through expression of ephrinA5 from NG2 (show Vcan Proteins)(+) cells
The NG2 (show Vcan Proteins) proteoglycan (show Vcan Proteins) protects oligodendrocyte precursor cells against oxidative stress via interaction with OMI/HtrA2 (show HTRA2 Proteins).
NG2 (show Vcan Proteins) ablation leads to reduced LDL sequestration in the aorta and reduced atherogenesis.
This study demonstrated that a pathway and role for NG2 (show Vcan Proteins) glia in central nerve system homeostasis and mood disorders.
cleaved by ADAM10 (show ADAM10 Proteins) and the gamma-secretase on oligodendrocyte precursor cells
of NG2/CSPG4 rather than changes in CD44 (show CD44 Proteins) or Ki-67 (show MKI67 Proteins) expression is associated with low overall survival in glioblastoma multiforme patients
The results indicate that CSPG4/NG2 has roles in regulating chondrosarcoma cell function in relation to growth, spread and resistance to chemotherapy.
A positive CSPG4 stain may be associated with an increased risk of metastasis and mortality from chordoma.
CSPG4 is a cell surface proteoglycan (show Vcan Proteins) regulated by interleukin 11 (show IL11 Proteins) in human endometrial epithelial cancer cells. the data suggest that CSPG4 inhibition may impair endometrial cancer progression by reducing cancer cell proliferation, migration and potentially epithelial-to-mesenchymal transition.
These data suggest the possible involvement of GD3 and NG2 in pre/pro-tumorigenic events occurring in the complex microenvironment of the tissue surrounding glioblastoma
the ratio of serum proteoglycan 4 (show PRG4 Proteins) to protease C1 inhibitor (show SERPING1 Proteins) may be used for screening of early breast cancer.
The NG2 proteoglycan (show Vcan Proteins) protects oligodendrocyte precursor cells against oxidative stress via interaction with OMI/HtrA2 (show HTRA2 Proteins).
The up-regulation of NG2 is associated with poor prognosis in HCC (show FAM126A Proteins).
Low CSPG4 expression is associated with pancreatic tumors.
These data are consistent with the concept that expression of inhibitory CSPG within the injury scar is an important impediment to regeneration but that NG2+ progenitors derived from ESNLCs can modify the microenvironment
A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells.
, AN2/NG2 proteoglycan
, chondroitin sulfate proteoglycan NG2
, nerve/glial antigen 2
, proteoglycan AN2
, chondroitin sulfate proteoglycan 4 (melanoma-associated)
, melanoma chondroitin sulfate proteoglycan
, melanoma-associated chondroitin sulfate proteoglycan
, HSN tumor-specific antigen
, membrane-spanning proteoglycan NG2
, E3 ubiquitin-protein ligase RNF5